Informed shared decision making about immunotherapy for patients with multiple sclerosis (ISDIMS): a randomized controlled trial

Background and purpose:  To evaluate the effects of an evidence‐based patient decision aid (DA) on multiple sclerosis (MS) immunotherapy.

[1]  L. Munari,et al.  Interferon in relapsing-remitting multiple sclerosis. , 2001, The Cochrane database of systematic reviews.

[2]  Aileen Clarke,et al.  Developing a quality criteria framework for patient decision aids: online international Delphi consensus process , 2006, BMJ : British Medical Journal.

[3]  L. Munari,et al.  Interferons in relapsing remitting multiple sclerosis : a systematic review , 2022 .

[4]  J A Sloan,et al.  The Control Preferences Scale. , 1997, The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres.

[5]  A. D. Kennedy.  On what basis should the effectiveness of decision aids be judged? , 2003, Health expectations : an international journal of public participation in health care and health policy.

[6]  D. Kiesler,et al.  Optimal matches of patient preferences for information, decision-making and interpersonal behavior: evidence, models and interventions. , 2006, Patient education and counseling.

[7]  L. Durelli,et al.  Adherence to interferon-beta treatment and results of therapy switching , 2007, Journal of the Neurological Sciences.

[8]  J. G. Adair,et al.  The Hawthorne effect: A reconsideration of the methodological artifact. , 1984 .

[9]  M Nübling,et al.  Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial , 2009, Multiple sclerosis.

[10]  D. Cegala.  Patient communication skills training: a review with implications for cancer patients. , 2003, Patient education and counseling.

[11]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[12]  S. Kaplan,et al.  Expanding patient involvement in care. Effects on patient outcomes. , 1985, Annals of internal medicine.

[13]  John E. Ware,et al.  Expanding Patient Involvement in Care , 1985 .

[14]  W. F. Miser,et al.  The other half of the whole: teaching patients to communicate with physicians. , 2002, Family medicine.

[15]  Martin Härter,et al.  Participation preferences of patients with acute and chronic conditions , 2007, Health expectations : an international journal of public participation in health care and health policy.

[16]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.

[17]  B. Weinshenker,et al.  Not every patient with multiple sclerosis should be treated at time of diagnosis. , 2006, Archives of neurology.

[18]  Jürgen Kasper,et al.  MATRIX - development and feasibility of a guide for quality assessment of patient decision aids , 2007, Psycho-social medicine.

[19]  Amiram Gafni,et al.  What do we mean by partnership in making decisions about treatment? , 1999, BMJ.

[20]  L. Degner,et al.  Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis. , 1994, Social science & medicine.

[21]  I. Mühlhauser,et al.  Evidence-based patient information about treatment of multiple sclerosis--a phase one study on comprehension and emotional responses. , 2006, Patient education and counseling.

[22]  Jürgen Kasper,et al.  Decisional role preferences, risk knowledge and information interests in patients with multiple sclerosis , 2004, Multiple sclerosis.